Cargando…

Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes

Iron overload may represent an additional clinical problem in patients with Myelodysplastic Syndromes (MDS), with recent data suggesting prognostic implications. Beyond red blood cells transfusions, dysregulation of hepcidin, the key iron hormone, may play a role, but studies until now have been ham...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santini, Valeria, Girelli, Domenico, Sanna, Alessandro, Martinelli, Nicola, Duca, Lorena, Campostrini, Natascia, Cortelezzi, Agostino, Corbella, Michela, Bosi, Alberto, Reda, Gianluigi, Olivieri, Oliviero, Cappellini, Maria Domenica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158762/ https://www.ncbi.nlm.nih.gov/pubmed/21886780 http://dx.doi.org/10.1371/journal.pone.0023109

Ejemplares similares

Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study()
por: Campostrini, Natascia, et al.
Publicado: (2012)

Evaluation of Hepcidin Isoforms in Hemodialysis Patients by a Proteomic Approach Based on SELDI-TOF MS
por: Campostrini, Natascia, et al.
Publicado: (2010)

Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study
por: Martinelli, Nicola, et al.
Publicado: (2012)

Iron deficiency in the elderly population, revisited in the hepcidin era
por: Busti, Fabiana, et al.
Publicado: (2014)

Correction: Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study
por: Martinelli, Nicola, et al.
Publicado: (2013)

Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass Spectrometry
por: Swinkels, Dorine W., et al.
Publicado: (2008)

The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis
por: Pelusi, Serena, et al.
Publicado: (2013)

Sucrosomial(®) Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation
por: Asperti, Michela, et al.
Publicado: (2018)

High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics
por: Polati, Rita, et al.
Publicado: (2009)

A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels
por: Lira Zidanes, Acaynne, et al.
Publicado: (2020)

Lenalidomide in the Treatment of Chronic Lymphocytic Leukemia
por: Cortelezzi, Agostino, et al.
Publicado: (2012)

Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?
por: Mariani, Marianna, et al.
Publicado: (2020)

Access Rate to the Emergency Department for Venous Thromboembolism in Relationship with Coarse and Fine Particulate Matter Air Pollution
por: Martinelli, Nicola, et al.
Publicado: (2012)

Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele
por: Olivieri, Oliviero, et al.
Publicado: (2013)

Hepcidin antagonists for potential treatments of disorders with hepcidin excess
por: Poli, Maura, et al.
Publicado: (2014)

Angiogenesis in myelodysplastic syndromes
por: Pruneri, G, et al.
Publicado: (1999)

Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII
por: Olivieri, Oliviero, et al.
Publicado: (2019)

Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine
por: Valencia, A, et al.
Publicado: (2014)

Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease
por: Cavallari, Ugo, et al.
Publicado: (2007)

Hepcidin is potential regulator for renin activity
por: Piesanen, Jaakko, et al.
Publicado: (2022)

Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes
por: Park, Sophie, et al.
Publicado: (2019)

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study
por: Reda, Gianluigi, et al.
Publicado: (2018)

Iron Stores, Hepcidin, and Aortic Stiffness in Individuals with Hypertension
por: Valenti, Luca, et al.
Publicado: (2015)

Novel protein-truncating variant in the APOB gene may protect from coronary artery disease and adverse cardiovascular events
por: Mango, Gabriele, et al.
Publicado: (2022)

Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25
por: Cenci, Lucia, et al.
Publicado: (2015)

Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-Syndrome-Related Risk of Coronary Artery Disease
por: Martinelli, Nicola, et al.
Publicado: (2012)

Development of interactive algorithm for clinical management of acute events related to sickle cell disease in emergency department
por: Forni, Gian Luca, et al.
Publicado: (2014)

Molecular Mechanisms Regulating Hepcidin Revealed by Hepcidin Disorders
por: Camaschella, Clara, et al.
Publicado: (2011)

Hepcidin Therapeutics
por: Katsarou, Angeliki, et al.
Publicado: (2018)

Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin
por: Galesloot, Tessel E., et al.
Publicado: (2016)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
por: Poli, Maura, et al.
Publicado: (2017)

Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures
por: Masala, Erico, et al.
Publicado: (2018)

Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease
por: Pizzolo, Francesca, et al.
Publicado: (2021)

Hepcidin is elevated in mice injected with Mycoplasma arthritidis
por: Koening, Curry L, et al.
Publicado: (2009)

Hepcidin and sports anemia
por: Kong, Wei-Na, et al.
Publicado: (2014)

Hepcidin in neoplastic disease
por: Nicolae, CD, et al.
Publicado: (2013)

Hepcidin in hepatocellular carcinoma
por: Joachim, Jonathan H., et al.
Publicado: (2022)

Evidence of non-transferrin-bound iron in patients with ST-elevation myocardial infarction: relationship with microvascular obstruction and post-reperfusion myocardial hemorrhage
por: Roghi, Alberto, et al.
Publicado: (2015)

Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting
por: Girelli, Domenico, et al.
Publicado: (2006)

Additive effect of LRP8/APOER2 R952Q variant to APOE ε2/ε3/ε4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study
por: Martinelli, Nicola, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dv8prkkadcr5ackr62agc8munu